Delegation Comprised of Business, Government and Academic Leaders

• Collaboration starts with immunotherapy for life-threatening food allergies
• Novel therapies engineered to produce immune tolerance for two additional antigens to abate allergic immune response in people with severe allergies

Experimental technology could transform field of lung transplantation

ANDOVER, Mass., Nov. 27, 2012 — /PRNewswire/ -- TransMedics, Inc., the global leader in organ preservation technology, announced the closing of a $36 million financing round led by Abrams Capital with the participation of existing investors including Flagship Ventures, Hercules Technology Growth Capital and Kleiner Perkins Caufield & Byers.

Marcy l’Etoile (France) and Lexington, MA (U.S.) – November 15, 2012 — bioMérieux and Quanterix announced today that they have entered into a strategic agreement that gives bioMérieux worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications. Under the agreement, Quanterix will deliver a new instrument and consumables based on its Simoa technology. bioMérieux will develop ultra-sensitive and multiplex assays on the platform.

LEXINGTON, Mass., Nov 14, 2012 (BUSINESS WIRE) -- T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued two patents adding depth and breadth to the Company's intellectual property portfolio. These patents cover both the device and methods related to the Company's flagship T2Candida assay and the detection of additional biological analytes, including specific drug and biomarker targets, in biological samples using the T2MR platform.

WALTHAM, MA, USA (November 14, 2012) – Affinnova, Inc., the global leader in innovation software and services, today announced it ranked 274 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Affinnova grew 279 percent during this period.

This year's 200 top, private greentech companies -- plus 30 to watch -- are taking maturing greentech research and pairing it with innovative technology solutions to change the way we live our lives for the better.

WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD) today reported financial results for the third quarter ended September 30, 2012 and provided a business update.